| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 12/02/2003 | US6656696 Compositions and methods for monitoring the phosphorylation of natural binding partners |
| 12/02/2003 | US6656695 Biomap characterization of biologically active agents |
| 12/02/2003 | US6656693 Self assembled nano-devices using DNA |
| 12/02/2003 | US6656692 Complexing |
| 12/02/2003 | US6656691 TCF-1 nucleotide sequence variation |
| 12/02/2003 | US6656690 Determining the three dimensional structure of preferential nucleic; obtain chimeric nucleotide sequences, ionize nucleotide sequences, recover fragmentation, generate three dimensional structure |
| 12/02/2003 | US6656689 Hybridization probes derived from the spacer region between the 16S and 23S rRNA genes for the detection of non-viral microorganisms |
| 12/02/2003 | US6656687 Peptide nucleic acid (PNA); in-situ hybridization (ISH); probes for detection of bacteria or eucarya in food, beverage, water, pharmaceutical/personal care/dairy products |
| 12/02/2003 | US6656686 Method of simultaneous detection of base changes (SDBC) in expressed genes |
| 12/02/2003 | US6656685 Hybridization buffers using low molecular weight dextran sulfate and methods for their use |
| 12/02/2003 | US6656684 Method for predicting tumor recurrence |
| 12/02/2003 | US6656682 Nucleic acid-immobilized substrate |
| 12/02/2003 | US6656681 Polycystic kidney disease 12 gene and uses thereof |
| 12/02/2003 | US6656680 Detecting preferential nucleotide sequences in sample; obtain sample nucleotide sequences, incubate with primers, detect reporter molecules |
| 12/02/2003 | US6656677 Genetic engineered libraries |
| 12/02/2003 | US6656480 Nucleotide sequences which code polypeptide for use the treatment of mammary gland cancer |
| 12/02/2003 | US6656471 Monitoring HLA-Cw7-restricted CTL response; AIDS prevention |
| 12/02/2003 | US6656432 Micropipette and dividedly injectable apparatus |
| 12/02/2003 | CA2390250A1 Detection of infectious hematopoietic necrosis virus |
| 12/02/2003 | CA2303277C Apparatus for a fluid impingement thermal cycler |
| 12/02/2003 | CA2267524C Identifying antisense oligonucleotide binding |
| 12/02/2003 | CA2218017C Dna sequencing by parallel oligonucleotide extensions |
| 12/02/2003 | CA2126438C Site-directed mutagenesis of dna |
| 11/30/2003 | CA2388659A1 Phospholipase a2 expression and activity and use thereof for diagnosis, prognostication, prevention and treatment of neural inflammatory and demyelinating disease |
| 11/30/2003 | CA2388445A1 Genetic markers, metabolic markers, and methods for evaluating pathogenicity of strains of e. coli |
| 11/29/2003 | WO2003096988A2 Tr4/tr2 response elements |
| 11/29/2003 | CA2486351A1 Tr4/tr2 response elements |
| 11/28/2003 | WO2001092572A1 Kit and method for determining hla type |
| 11/28/2003 | CA2413931A1 Kit and method for determining hla types |
| 11/27/2003 | WO2003098661A2 Chemical and biological hazard sensor system and methods thereof |
| 11/27/2003 | WO2003098223A2 A method for killing cells by inhibiting histone activity in the cell |
| 11/27/2003 | WO2003098222A1 Polymorphism of soati useful for identifying risk of developing alzheimer's disease |
| 11/27/2003 | WO2003098216A1 Bioassay method, bioassay device, and bioassay substrate |
| 11/27/2003 | WO2003098214A1 Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species |
| 11/27/2003 | WO2003098212A2 Method of isolating an endotehelial cell and method of donor specific crossmatching |
| 11/27/2003 | WO2003098210A1 Method for the determination of changes in a cellular morphological parameter |
| 11/27/2003 | WO2003098190A2 Protein identification from protein product ion spectra |
| 11/27/2003 | WO2003098187A2 Assays and kits for detecting the presence of nitriles and/or cyanide |
| 11/27/2003 | WO2003098184A2 Method for identifying modulators of sulfotransferase activity |
| 11/27/2003 | WO2003098165A1 Biosensor having electrode for determining the rate of flow of a liquid |
| 11/27/2003 | WO2003097879A2 Method of identifying pancreatic ductal carcinoma-specific gene using pancreatic ductal cells, method of testing for pdc using said genes, and method of screening pharmaceutical candidate compounds for treating or preventing pdc |
| 11/27/2003 | WO2003097878A1 Nucleic acid amplification primers for detecting cytokeratins and examination method with the use of the primers |
| 11/27/2003 | WO2003097877A1 Method of detecting gene polymorphism |
| 11/27/2003 | WO2003097876A1 Method for improving efficiencies in livestock production |
| 11/27/2003 | WO2003097875A1 Diagnosis of abnormal blood conditions based on polymorphisms in the glycoprotein vi gene |
| 11/27/2003 | WO2003097874A1 Method for parallel preparation of rna and proteins from a tissue sample |
| 11/27/2003 | WO2003097873A2 Polymorphisms in the human gene for htr3b and their use in diagnostic and therapeutic applications |
| 11/27/2003 | WO2003097872A2 G - protein coupled receptor marker molecules associated with colorectal lesions |
| 11/27/2003 | WO2003097871A2 Marker molecules associated with lung tumors |
| 11/27/2003 | WO2003097870A2 Method for detection of somatic mutations |
| 11/27/2003 | WO2003097869A2 Microsatellite markers for genetic analyses and the differentiation of roses |
| 11/27/2003 | WO2003097868A1 Identification of eukaryotic species using probes derived from the intergenic region of pairs of divergently transcribed histone genes |
| 11/27/2003 | WO2003097867A1 Detection of kinase substrates and products using ion mass spectrometry |
| 11/27/2003 | WO2003097866A1 Biosensor |
| 11/27/2003 | WO2003097865A1 Method of preventing wrong color formation of n-(carboxymethylaminocarbonyl)-4,4'-bis(dimethylamino)diphenylamine sodium, reagent solution for the method, and measurement method employing the method |
| 11/27/2003 | WO2003097864A1 Method and reagent system having a non-regenerative enzyme-coenzyme complex |
| 11/27/2003 | WO2003097863A1 Method and reagent system having an inactivated enzyme |
| 11/27/2003 | WO2003097862A1 Method of searching substane having antidiabetic activity |
| 11/27/2003 | WO2003097861A1 Method and device for detecting toxic material in water using microbial fuel cell |
| 11/27/2003 | WO2003097860A1 Analyte measurement |
| 11/27/2003 | WO2003097859A2 Method for producing polymer layers |
| 11/27/2003 | WO2003097858A1 Identification method for protecting products |
| 11/27/2003 | WO2003097857A2 Method for the detection of aquaretic compounds |
| 11/27/2003 | WO2003097856A2 Plating media |
| 11/27/2003 | WO2003097854A2 Novel biomarkers of tyrosine kinase inhibitor exposure and activity in mammals |
| 11/27/2003 | WO2003097853A2 Method of screening anti-bacterial agents for effectiveness in treating persistent intracellular infections |
| 11/27/2003 | WO2003097852A2 Assay for identifying inhibitors of fc gamma riii signaling |
| 11/27/2003 | WO2003097850A1 Simulating microarrays using a parameterized model |
| 11/27/2003 | WO2003097846A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
| 11/27/2003 | WO2003097845A1 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva) |
| 11/27/2003 | WO2003097834A2 A method for in vitro molecular evolution of protein function |
| 11/27/2003 | WO2003097831A1 Method for nucleic acid extraction and nucleic acid purification |
| 11/27/2003 | WO2003097830A1 Method of judging sensibility to imatinib |
| 11/27/2003 | WO2003097828A1 Method of identifying nucleic acid |
| 11/27/2003 | WO2003097823A1 Regulation of human serine/threonine kinase |
| 11/27/2003 | WO2003097816A1 Method of effecting lysis of acid-fast bacteria and method of performing gene amplification or detection therewith |
| 11/27/2003 | WO2003097815A2 Molecular identification of aspergillus species |
| 11/27/2003 | WO2003097811A2 Cellular gene targets for controlling cell growth |
| 11/27/2003 | WO2003097808A2 Automated system for isolating, amplyifying and detecting a target nucleic acid sequence |
| 11/27/2003 | WO2003097803A2 Cancer-linked gene as target for chemotherapy |
| 11/27/2003 | WO2003097795A2 Constitutively translocating cell line |
| 11/27/2003 | WO2003097794A2 Universal-tagged oligonucleotide primers and methods of use |
| 11/27/2003 | WO2003097793A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 11/27/2003 | WO2003097791A2 Polynucleotide sequences encoding alkaline a-galactosidases and methods of using same |
| 11/27/2003 | WO2003097789A2 Farnesyl diphosphate synthase from pseudomonas aeruginosa |
| 11/27/2003 | WO2003097786A1 Conductive microplate |
| 11/27/2003 | WO2003097686A1 Novel protein, its dna and use thereof |
| 11/27/2003 | WO2003097683A2 Human obesity susceptibility gene and uses thereof |
| 11/27/2003 | WO2003097667A1 Methods for measuring kinase activity and phosphatase activity |
| 11/27/2003 | WO2003097666A2 Use of gastrin releasing peptide (grp) and its receptor in cancer screening |
| 11/27/2003 | WO2003097665A2 Mid 241 receptor, a novel g-protein coupled receptor |
| 11/27/2003 | WO2003097237A2 Protease inhibitor sample collection system |
| 11/27/2003 | WO2003097049A1 Anti-estrogen receptor agents for chemotherapy and prevention |
| 11/27/2003 | WO2003096985A2 3d structure of the tsg101 uev domain |
| 11/27/2003 | WO2003096971A2 Diagnosis of glaucoma |
| 11/27/2003 | WO2003096969A2 Novel lambda phage display system and the process |
| 11/27/2003 | WO2003096964A2 Means for use in treating diseases correlated with or caused by non-physiological levels of microtubule-associated pp2ac |
| 11/27/2003 | WO2003096799A2 Multiple closed nucleus breeding for swine production |
| 11/27/2003 | WO2003087188A8 Oligonucleotide-modified romp polymers and co-polymers |
| 11/27/2003 | WO2003083096A3 Cancer associated protein kinases and their uses |